Financial Highlights

Japanese[Open in a new window]

Operating Results and Financial Position (annual)

For the fiscal year ended March 31, 2021, revenue decreased by 139,788 million yen (23.7%) year on year to 451,223 million yen, operating loss amounted to 56,241 million yen (compared to operating profit of 6,751 million yen for the previous fiscal year), loss before tax amounted to 45,342 million yen (compared to profit before tax of 11,864 million yen for the previous fiscal year), and loss attributable to owners of parent amounted to 34,497 million yen (compared to profit attributable to owners of parent of 7,693 million yen).

[ Imaging Products Business ]
Among the digital camera-interchangeable lens type, sales of full-frame mirrorless cameras Z 7II and Z 6II remained strong. In this business segment, the Group sought to expand sales of mid- to high-end products to professionals and hobbyists by enhancing the lineup of interchangeable lenses for mirrorless cameras.
However, unit sales declined on the back of market shrinkage besides subdued demand amid the spread of COVID-19.
As a result, in the Imaging Products Business segment, the Group recorded revenue of 150,218 million yen (down 33.5 % year on year), and operating loss of 35,779 million yen (compared to operating loss of 17,153 million yen for the previous fiscal year) for the reasons such as the recognition of impairment loss on non-current assets and restructuring costs.

[ Precision Equipment Business ]
In the FPD lithography system field, the Group resumed installations in July 2020, and as a result, overall unit sales increased. However, unit sales of systems for supporting the 10.5th-generation plate declined due in part to travel restrictions amid the spread of COVID-19, resulting in decreased revenue and profit.
In the semiconductor lithography system field, unit sales declined, and as a consequence, revenue declined partly due to the Group’s major customer being at their shifting point of investment. Also, profit declined due in part to disposal and write-down of inventories including some systems and recognition of impairment loss on non-current assets.
As a result, in the Precision Equipment Business segment, the Group recorded revenue of 184,777 million yen (down 24.6 % year on year), and operating profit of 1,400 million yen (down 97.1 % year on year).

[ Healthcare Business ]
Revenues from the bioscience and ophthalmic diagnosis fields combined declined during the first half under the influence of the spread of COVID-19. On a full-year basis, however, this business segment finished the fiscal year with increased revenue, driven by record-high sales from the ophthalmic diagnosis field which performed strongly.
As a result, in the Healthcare Business segment, the Group recorded revenue of 62,848 million yen (up 1.3 % year on year), but recorded operating loss of 3,091 million yen (compared to operating loss of 2,455 million yen for the previous fiscal year) due to the recognition of impairment loss on non-current assets, despite improved margins in both fields.

[ Industrial Metrology and Others ]
In the Industrial Metrology segment, the Group recorded decreased revenue due to subdued investments and restrained sales activities by customers in the face of the spread of COVID-19. However, profit from the business picked up owing to the write-down of goodwill during the previous fiscal year and Group’s efforts such as cost cutting.
In the Digital Solutions Business, the Group recorded increased revenue, helped by strong sales of optical parts & components and encoders.
In the Customized Products Business, revenue associated with the space-related fields increased, while revenue associated with solid-state laser decreased.
As a result, in the Industrial Metrology and Others Business segment, the Group recorded revenue of 53,381 million yen (down 8.1 % year on year), and operating loss of 2,626 million yen (compared to operating profit of 1,895 million yen for the previous fiscal year) due to recognition of impairment loss on non-current assets in connection with the Imaging Products business at domestic production bases and land improvement costs incurred by a subsidiary.